ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,115Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 18

$393K Total Retail Price of All Prescriptions

Rank: 7 out of 18

262 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 262 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 262 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 393 343 81 1 6
LISINOPRIL 298 283 63 2 3
SIMVASTATIN 273 258 53 3 7
WARFARIN SODIUM 250 245* 19 4 1
FUROSEMIDE 250 228 58 4 2
ATORVASTATIN CALCIUM 229 201 46 6 9
METOPROLOL SUCCINATE 198 193* 45 7 21
METOPROLOL TARTRATE 188 183* 40 8 8
HYDROCODONE-ACETAMINOPHEN 184 172 31 S3 9 20
LEVOTHYROXINE SODIUM 171 156 35 10 4
TRAZODONE HCL 163 148 40 11 11
AMLODIPINE BESYLATE 149 138 43 12 5
CITALOPRAM HBR 139 134* 26 13 16
CLOPIDOGREL 127 122* 20 14 23
SPIRIVA 121 100 26 15 37
DONEPEZIL HCL 121 116* 21 15 12
METFORMIN HCL 117 102 25 17 19
OXYCONTIN 114 <11 <11 S2 18 64
ADVAIR DISKUS 112 82 24 19 44
TRAMADOL HCL 112 75 26 19 42
GABAPENTIN 108 94 23 21 17
CYMBALTA 107 107 14 22 28
SERTRALINE HCL 105 81 25 23 10
HYDROCHLOROTHIAZIDE 97 92* 22 24 15
ESCITALOPRAM OXALATE 89 89 15 25 29
LANTUS 87 82* 22 26 34
PANTOPRAZOLE SODIUM 87 69 20 26 30
OXYCODONE-ACETAMINOPHEN 86 81* 11 S2 28 88
RISPERIDONE 85 <11 <11 A 29 55
MIRTAZAPINE 80 75* 23 30 14
POLYETHYLENE GLYCOL 3350 79 74* 32 31 25
MONTELUKAST SODIUM 75 64 11 32 76
PRAVASTATIN SODIUM 74 69* 14 33 26
CLONAZEPAM 66 61* 11 B 34 47
PREDNISONE 65 49 23 35 33
TAMSULOSIN HCL 60 60 19 36 27
METFORMIN HCL ER 60 55* 17 36 93
VENTOLIN HFA 59 46 26 38 164
GLIPIZIDE XL 59 59 13 38 126
QUETIAPINE FUMARATE 58 53* 14 A 40 18
LIDODERM 57 52* 11 41 48
LOSARTAN POTASSIUM 55 42 12 42 24
NAMENDA 53 53 11 43 13
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.